Jaguar Health Inc.
JAGX | NASDAQ
$0.87
-$0.75 (-46.30%)
At close: Nov 2, 2026, 3:59 PM ET
$0.85
-$0.02 (-2.67%)
After-hours:
Nov 2, 2026, 6:55 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 11.51M | 11.69M | 9.76M | 11.96M | 4.34M | 9.39M |
Cost of Revenue | 3.77M | 1.96M | 2.04M | 2.02M | 2.33M | 3.28M |
Gross Profit | 7.74M | 9.73M | 7.72M | 9.94M | 2M | 6.11M |
Operating Income | -45.11M | -30.83M | -34.29M | -34.42M | -40.71M | -26.65M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 2.79M |
Pretax Income | -54M | -39.25M | -41.9M | -48.4M | -52.6M | -33.81M |
Net Income | -53.43M | -38.49M | -41.3M | -47.45M | -52.6M | -33.81M |
Selling & General & Admin | 26.02M | 24.02M | 23.05M | 26.71M | 26M | 21M |
Research & Development | 24.97M | 16.54M | 18.6M | 17.65M | 15.08M | 6.41M |
Other Expenses | 1.86M | n/a | 371K | n/a | 1.63M | 5.34M |
Operating Expenses | 52.85M | 40.57M | 42.02M | 44.35M | 42.71M | 32.75M |
Interest Expense | -67K | 231K | 6.38M | 12.72M | 8.42M | 2.79M |
Selling & Marketing Expenses | 4.17M | 7.69M | 6.46M | 8.84M | 8.89M | 6.61M |
Cost & Expenses | 56.62M | 42.52M | 44.05M | 46.37M | 45.04M | 36.03M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 4.44K | 561 | 29.29 | 1.67 | 0.76 | 0.22 |
Shares Outstanding (Diluted) | 4.44K | 561 | 29.29 | 1.67 | 0.76 | 0.22 |
EPS (Basic) | -12.06K | -68.61K | -1.41M | -28.49M | -69.48M | -177.21M |
EPS (Diluted) | -12.06K | -68.61K | -1.41M | -28.49M | -69.48M | -177.21M |
EBITDA | -51.73M | -36.66M | -32.76M | -33.38M | -42.37M | -28.74M |
EBIT | -53.93M | -39.02M | -33.92M | -35.67M | -44.18M | -31.02M |
Depreciation & Amortization | 2.2M | 2.36M | 1.16M | 2.29M | 1.81M | 2.28M |
Add to Watchlist
Select watchlists to add or remove JAGX